Dana-Farber/Partners Cancer Care

Boston, Massachusetts 02215

0 studies enrolling now · 7 studies all time

What they study most

Carcinoma, Hepatocellular, Ewing/Ewing-like Sarcoma, Fallopian Cancer, Liposarcoma, Lung Cancer, Mesenchymal Chondrosarcoma, Multiple Myeloma, Non-small Cell Lung Cancer, Osteogenic Sarcoma, Ovarian Cancer, Peritoneal Cancer, Rhabdomyosarcoma

Studies at this site

• An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer — Completed
• SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes — Completed
• Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143 — Completed
• Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma — Completed
• A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care — Stopped early
• Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer — Completed
• Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer — Status unconfirmed